Data / Form D filings / Gemelli Biotech Corp.
Gemelli Biotech Corp.: Form D filings
Gemelli Biotech Corp., a biotechnology company in Raleigh, NC, filed 5 Form D notices with the SEC between 2019 and 2024. The latest, on December 2, 2024, reports $21.2 million sold of a $23.9 million offering to 128 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2009 Fairview Rd. #6099, Raleigh, NC, 27628
- Phone
- (919) 451-0533
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1780605
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Amendment | $23,910,940 | $21,176,893 | $2,734,047 | 128 | Dec 7, 2021 | sec.gov |
| Jun 8, 2022 | New notice | $19,967,887 | $18,910,941 | $1,056,946 | 121 | Dec 7, 2021 | sec.gov |
| Mar 29, 2021 | Amendment | $5,500,000 | $5,500,000 | 85 | Dec 23, 2019 | sec.gov | |
| Mar 26, 2021 | New notice | $5,000,000 | $5,000,000 | 85 | Dec 23, 2019 | sec.gov | |
| Jun 28, 2019 | New notice | $2,999,999 | $1,854,978 | $1,145,021 | 13 | Jun 14, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John A. Neczesny | Director | |
| Matthew Mitcho | Executive Officer, Director | |
| Oded A. Levy | Director | |
| Ritish A. Agarwal | Director | |
| James Laur | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Dec 2, 2024 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gemelli Biotech Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.